Nalaganje...
Ticagrelor therapy and atrioventricular block: Do we need to worry?
Ticagrelor is a potent, direct P2Y12 antagonist with rapid onset of action and intense platelet inhibition, indicated in patients with acute coronary syndromes (ACS). This drug is usually well tolerated, but some patients experience serious adverse effects: Major bleeding; gastrointestinal disturban...
Shranjeno v:
| izdano v: | World J Clin Cases |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5434317/ https://ncbi.nlm.nih.gov/pubmed/28560235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v5.i5.178 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|